Preadmission use of warfarin improves short-term outcome in patients with acute cerebral infarction

Cerebrovascular Diseases

Volumn 28, Issue 1, 2009, Pages 8-12

  Naess, Halvor ^a   Brogger, Jan ^a   Waje Andreassen, Ulrike ^a   Idicula, Titto T ^a   Thomassen, Lars ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Cerebral infarction; Short term prognosis; Warfarin

Indexed keywords

WARFARIN;

ACUTE CEREBRAL INFARCTION; ACUTE DISEASE; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCARDIOGRAM; EMBOLISM; FEMALE; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HOSPITAL ADMISSION; HUMAN; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STROKE;

ACUTE DISEASE; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBRAL INFARCTION; FEMALE; HUMANS; LINEAR MODELS; MALE; NERVOUS SYSTEM DISEASES; NORWAY; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TIME FACTORS; WARFARIN;

EID: 65449183797     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000215937     Document Type: Article

References (15)

1. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154:1449-1457.
2. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999; 131: 492-501.
3. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high- risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633- 638.
4. O'Donnell M, Oczkowski W, Fang J, Kearon C, Silva J, Bradley C, Guyatt G, Gould L, D'Uva C, Kapral M, Silver F: Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol 2006;5:749-754.
5. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE: Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-1026.
6. Indredavik B, Rohweder G, Lydersen S: Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation. J Intern Med 2005;258:133-144.
7. Johnson CJ, Kittner SJ, McCarter RJ, Sloan MA, Stern BJ, Buchholz D, Price TR: Inter- rater reliability of an etiologic classification of ischemic stroke. Stroke 1995;26:46-51.
8. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd:Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 inAcute Stroke Treatment. Stroke 1993;24:35- 41.
9. Indredavik B, Bakke F, Slordahl SA, Rokseth R, Haheim LL: Treatment in a combined acute and rehabilitation stroke unit: which aspects are most important? Stroke 1999;30:917-923.
10. Ay H, Arsava EM, Gungor L, Greer D, Sin- ghal AB, Furie KL, Koroshetz WJ, Sorensen AG: Admission international normalized ratio and acute infarct volume in ischemic stroke. Ann Neurol 2008; 64:499-506.
11. Ellekjaer H, Selmer R: Stroke - similar incidence, better prognosis. Tidsskr Nor Laege-foren 2007; 127: 740-743.
12. Vibo R, Korv J, Roose M: One-year outcome after first-ever stroke according to stroke subtype, severity, risk factors and pre-stroke treatment: a population-based study from Tartu, Estonia. Eur J Neurol 2007; 14: 435-439.
13. Pullicino P, Thompson JL, Mohr JP, Sacco RL, Freudenberger R, Levin B, Homma S: Oral anticoagulation in patients with car- diomyopathy or heart failure in sinus rhythm. Cerebrovasc Dis 2008; 26: 322-327.
14. Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, Bass EB: Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Cochrane Database Syst Rev 2001:CD001938.
15. Gustafsson C, Asplund K, Britton M, Norr- ving B, Olsson B, Marke LA: Cost-effectiveness of primary stroke prevention in atrial fibrillation: Swedish national perspective.BMJ 1992; 305:1457-1460.